Delivery Order 75N93021D00002-75N93021F00001
Award Date
10/15/20
Potential Completion Date
5/21/21
Potential Value
Not listed
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Alchem Laboratories Corporation
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AN81 - R&D- Medical: Aids Research (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Alachua, FL 32615, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This task order, awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Southern Research Institute, funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle. The purpose of this delivery order is to provide preclinical services in support of HIV therapeutics research and development efforts. With a potential value of $0.00 and cost-no-fee pricing, this task...
This task order funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle with the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Creagen Inc., an 8(a) small business, was awarded $0.00 to deliver preclinical services in support of HIV therapeutic development. Performance will occur in Woburn, Massachusetts through May 2021. No set-aside designation was applied to this order under the multiple awardIDIQ...
This task order funds the guaranteed minimum amount under the prime contract between Research Triangle Institute (RTI) International and the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose is to support preclinical services for HIV therapeutics research under the larger Preclinical Services for HIV Therapeutics master IDIQ contract vehicle. With a potential value of $0.00, this delivery order was awarded on October 15, 2020 to RTI...
This task order, awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases, funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract held by The University of Iowa. The purpose of this $0.00 delivery order is to provide preclinical services in support of developing therapeutics to treat HIV/AIDS. Set to be completed by May 2021, this award draws from the potential $0...
This task order funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle held by Sri International. The National Institute of Allergy and Infectious Diseases, a component of the Department of Health and Human Services' National Institutes of Health, awarded this $0 delivery order against the multiple award indefinite delivery/indefinite quantity master contract. Sri International will perform preclinical services in West Menlo Park, California in...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $0 delivery order against its Preclinical Services for HIV Therapeutics master IDIQ contract to Fisher Bioservices Inc., a division of Thermo Electron Corporation. The purpose of this task order is to fund the guaranteed minimum amount under the terms of the Preclinical Services for HIV Therapeutics contract vehicle. Performance will take place in Potomac, Maryland through June 2021. No...
Alchem Laboratories Corporation, doing business as Alchem Laboratories Corp., has been awarded a $17,148.47 delivery order against the Preclinical Services for HIV Therapeutics master indefinite-delivery/indefinite-quantity (IDIQ) contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose of this task order is for Alchem Laboratories to develop and deliver a quality assurance/quality control plan and participate in a task order initiation...
This task order, awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases, funds the guaranteed minimum amount under the agency's Preclinical Services for HIV Therapeutics contract vehicle. The $0 master indefinite delivery/indefinite quantity contract supports preclinical evaluation of candidate HIV therapeutics. The University of Nebraska Medical Center will perform these preclinical services as the prime contractor through June 2021, with...
This task order funds the guaranteed minimum amount under a preexisting master indefinite-delivery/indefinite-quantity contract between the National Institutes of Health's National Institute of Allergy and Infectious Diseases and Advanced Bioscience Laboratories, Inc. The purpose is to support preclinical and translational vaccine development for HIV and other candidate agents. The $2,500 delivery order was awarded on December 1, 2021 with a one-year period of performance ending November 30,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $0 delivery order against the Preclinical Services for HIV Therapeutics master IDIQ contract to the University of North Carolina at Chapel Hill Office of Sponsored Research. The purpose of this task order is to fund the guaranteed minimum amount of the contract to provide preclinical services in support of developing HIV therapeutics. Performance will take...